IBB vs IJH
iShares Biotechnology ETF vs iShares Core S&P Mid-Cap ETF
- • IJH has the lower expense ratio at 0.05% vs 0.44% for IBB.
- • IJH pays a higher dividend yield (1.23%).
Side-by-side metrics
| Metric | IBB | IJH |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.05% |
Dividend yield Trailing 12-month yield. | 0.16% | 1.23% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $123.20B |
YTD return | 30.22% | 13.60% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.99 |
P/E ratio | 25.48 | 19.23 |
Last price | $217.75 | $74.78 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
IJH top holdings
| OKTA | Okta Inc Class A | 1.01% |
| FTI | TechnipFMC PLC | 0.79% |
| UTHR | United Therapeutics Corp | 0.75% |
| ENTG | Entegris Inc | 0.69% |
| ATI | ATI Inc | 0.66% |
| USFD | US Foods Holding Corp | 0.65% |
| RS | Reliance Inc | 0.65% |
| XPO | XPO Inc | 0.65% |
| THC | Tenet Healthcare Corp | 0.64% |
| PR | Permian Resources Corp Class A | 0.64% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About IJH
IJH (iShares Core S&P Mid-Cap ETF) is Tracks the S&P MidCap 400 index. Managed by iShares, the fund carries $123.2B in assets under management, an expense ratio of 0.05%, a dividend yield of 1.23%. Its largest holding is Okta Inc Class A (OKTA), which represents 1.0% of the portfolio. Real Estate is the fund's largest sector exposure at 8.0%.